To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Prednisolone (Primary) ; Methylprednisolone acetate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Sun Pharmaceutical Industries
- 02 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2019.
- 02 Feb 2018 Planned primary completion date changed from 1 Aug 2017 to 1 Mar 2019.
- 21 Apr 2016 Status changed from not yet recruiting to recruiting.